Controlled Trial Highlights Therapeutic Benefits of Subthalamic Nucleus as a Target for Isolated Dystonia

A groundbreaking trial reveals that subthalamic deep brain stimulation effectively treats isolated dystonia, showing significant long-term motor and mental health improvements.:

Source: Neurology Read More

Previous PostExpanding Parkinson Treatment Options With Newly Approved Focused Ultrasound: Michael Kaplitt, MD, PhD
Next PostReal-World Data Highlight Patient-Reported Benefits of Intranasal Zavegepant for Acute Migraine

Controlled Trial Highlights Therapeutic Benefits of Subthalamic Nucleus as a Target for Isolated Dystonia

Previous PostExpanding Parkinson Treatment Options With Newly Approved Focused Ultrasound: Michael Kaplitt, MD, PhD

Next PostReal-World Data Highlight Patient-Reported Benefits of Intranasal Zavegepant for Acute Migraine

Related Posts

<![CDATA[How Early Environmental Detection Could Refine Parkinson Disease Risk Models: Rodolfo Savica, MD, PhD]]>

<![CDATA[TEMPO-4 Extension Analysis: Tavapadon Shows Levodopa-Sparing Potential in Parkinson Disease]]>

<![CDATA[Telitacicept Moves Forward in Global Phase 3 Study for Generalized Myasthenia Gravis]]>

Categories